News - Page 222 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Psychedelics Research Review: December 2020

Psychedelics Research Review: December 2020

Post published:January 7, 2021
Post category:Psychedelics Research Review

Read more about the article Tryp Therapeutics Appoints Dr. William K. Schmidt to Its Scientific Advisory Board

Tryp Therapeutics Appoints Dr. William K. Schmidt to Its Scientific Advisory Board

Post published:January 7, 2021
Post category:Press Release

Read more about the article NeonMind Appoints Trevor Millar as Chief Psychedelic Officer

NeonMind Appoints Trevor Millar as Chief Psychedelic Officer

Post published:January 7, 2021
Post category:Press Release

Read more about the article CYBIN Provides Update on Patent Filings & Development of Therapeutics Program

CYBIN Provides Update on Patent Filings & Development of Therapeutics Program

Post published:January 6, 2021
Post category:Press Release

Read more about the article Alberta Palliative Patient Successfully Undergoes First Legal Psychedelic-Assisted Therapy in Alberta, Initial Outcomes Exceed Expectations

Alberta Palliative Patient Successfully Undergoes First Legal Psychedelic-Assisted Therapy in Alberta, Initial Outcomes Exceed Expectations

Post published:January 6, 2021
Post category:Press Release

Read more about the article Silo Pharma Inc. Receives One Million Dollars in Up Front Licensing Deal for its Psilocybin Cancer Therapeutic Applications in a Combination of Cash and Equities

Silo Pharma Inc. Receives One Million Dollars in Up Front Licensing Deal for its Psilocybin Cancer Therapeutic Applications in a Combination of Cash and Equities

Post published:January 6, 2021
Post category:Press Release

Read more about the article Mindset Generates Promising In Vitro Results from Third Patent Family of Novel Psychedelic Compounds Suggesting Range of Potential Clinical Use Cases Including Micro-Dosing

Mindset Generates Promising In Vitro Results from Third Patent Family of Novel Psychedelic Compounds Suggesting Range of Potential Clinical Use Cases Including Micro-Dosing

Post published:January 6, 2021
Post category:Press Release

Read more about the article Numinus Signs Lab Services Agreement with Optimi Health to Advance Research and Development of Psychedelic Products

Numinus Signs Lab Services Agreement with Optimi Health to Advance Research and Development of Psychedelic Products

Post published:January 6, 2021
Post category:Press Release

Read more about the article Lobe Sciences Announces Further Upsizing and Second Closing of Non-Brokered Private Placement

Lobe Sciences Announces Further Upsizing and Second Closing of Non-Brokered Private Placement

Post published:January 6, 2021
Post category:Press Release

Read more about the article COMPASS Pathways plc to participate in HC Wainwright and ICR investor conferences

COMPASS Pathways plc to participate in HC Wainwright and ICR investor conferences

Post published:January 6, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.